Top compounds associated with response to RD3


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.05
mRNA HC-067047 CTRPv2 pan-cancer AAC 0.074 0.05
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.068 0.05
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.066 0.05
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.069 0.05
mRNA KPT185 CTRPv2 pan-cancer AAC 0.075 0.05
mRNA regorafenib CTRPv2 pan-cancer AAC 0.074 0.05
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.063 0.05
mRNA EX-527 CTRPv2 pan-cancer AAC 0.075 0.05
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.05
Download CSV